//
Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
Comparative analysis of recurrent events after presentation with an index myocardial infarction or ischaemic stroke
Clinician’s Guide to Reducing Inflammation to Reduce Atherothrombotic Risk
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association
Cardiopulmonary Exercise Testing: What Is its Value?